QAD Serialization Solution Helps Manufacturers Meet DQSA Requirements

Serialization helps ensure life science companies’ product integrity

SANTA BARBARA, Calif.--()--QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of cloud enterprise resource planning (ERP) solutions and services for global manufacturers, announced today the launch of its serialization solution to help life science companies meet the impending requirements of the U.S. Food and Drug Administration’s Drug Quality And Security Act (DQSA).

The DQSA outlines critical steps life science manufacturers must undertake to build an electronic, interoperable system to identify and trace prescription drugs distributed in the United States. This legislation is designed to help maintain patient safety while also deterring the production and distribution of counterfeit drugs.

QAD’s serialization solution allows for the integration of serialized line-level data and operational data and fully supports key customer requirements for lot and unit-level product tracking. It also simplifies regulatory compliance, manages serialized product and supports chain of custody tracking.

“QAD’s serialization solution manages packaging down to the smallest sellable unit with unique unit serial numbers, one of the requirements life science manufacturers must meet to comply with the DQSA legislation,” stated Bart Reitter, director, QAD Life Sciences. “In addition, our solution provides robust track and trace functionality which simplifies product recalls and helps protect consumers by helping to authenticate products and reduce counterfeits.”

About QAD – The Effective Enterprise

QAD Inc. (NASDAQ: QADA) (NASDAQ: QADB) is a leading provider of enterprise software and services designed for global manufacturing companies. For more than 35 years, QAD has provided global manufacturing companies with QAD Enterprise Applications, an enterprise resource planning (ERP) system that supports operational requirements, including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. QAD Enterprise Applications is offered in flexible deployment models as on-premise software, in the cloud with QAD Cloud ERP or in a blended environment. With QAD, customers and partners in the automotive, consumer products, food and beverage, high technology, industrial products and life sciences industries can better align daily operations with their strategic goals to meet their vision of becoming more Effective Enterprises.

For more information about QAD, call +1 805-566-6000, visit www.qad.com.

“QAD” is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.

Note to Investors: This press release contains certain forward-looking statements made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding projections of revenue, income and loss, capital expenditures, plans and objectives of management regarding the Company’s business, future economic performance or any of the assumptions underlying or relating to any of the foregoing. Forward-looking statements are based on the company’s current expectations. Words such as “expects,” “believes,” “anticipates,” “could,” “will likely result,” “estimates,” “intends,” “may,” “projects,” “should,” “would,” “might,” “plan” and variations of these words and similar expressions are intended to identify these forward-looking statements. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to: evolving demand for the company's products and companion products; the ability to sustain license and service demand; fluctuation in revenue and earnings in the software industry; the ability to leverage changes in technology; the ability to sustain customer renewal rates at current levels; third party opinions about the company; the reliability of estimates of transaction and integration costs and benefits; competition in our industry; delays in localizing the company's products for new or existing markets; the ability to recruit and retain key personnel; delays in sales; changes in operating expenses, pricing, timing of new product releases, the method of product distribution or product mix; timely and effective integration of newly acquired businesses; general economic conditions; exchange rate fluctuations; and, the global political environment. For a more detailed description of the risk factors associated with the company, please refer to the company's latest Annual Report on Form 10-K, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. Management does not undertake to update these forward-looking statements except as required by law.

Contacts

Markit Strategies
Patrick McLaughlin
734.255.6466
patrickm@markitstrategies.com
or
QAD Inc.
Evan Quinn
Analyst Relations
617.869.7335
industryanalyst@qad.com

Release Summary

QAD Inc., cloud ERP software provider, announced the launch of its serialization solution to help life science companies meet impending requirements of the FDA Drug Quality And Security Act (DQSA).

Contacts

Markit Strategies
Patrick McLaughlin
734.255.6466
patrickm@markitstrategies.com
or
QAD Inc.
Evan Quinn
Analyst Relations
617.869.7335
industryanalyst@qad.com